Original Research
Accepted on 11 Nov 2025
Gemcitabine-cisplatin chemotherapy plus anti-PD-L1 therapy reinvigorates anti-tumor immune response by reprogramming the intrahepatic cholangiocarcinoma microenvironment
in Cancer Immunity and Immunotherapy
- 116 views